On Tuesday, Angiodynamic Inc (NASDAQ: ANGO) was -13.53% drop from the session before settling in for the closing price of $13.23. A 52-week range for ANGO has been $8.27 – $13.99.
Annual sales at Healthcare sector company grew by 28.31% over the past five years. When this article was written, the company’s average yearly earnings per share was at -102.22%. With a float of $38.85 million, this company’s outstanding shares have now reached $41.57 million.
Angiodynamic Inc (ANGO) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Angiodynamic Inc stocks. The insider ownership of Angiodynamic Inc is 5.70%, while institutional ownership is 95.61%. The most recent insider transaction that took place on Oct 21 ’25, was worth 118,100. In this transaction SVP, Chief Legal Officer of this company bought 10,000 shares at a rate of $11.81, taking the stock ownership to the 93,597 shares. Before that another transaction happened on Oct 13 ’25, when Company’s EVP and CFO bought 890 for $11.16, making the entire transaction worth $9,932. This insider now owns 256,629 shares in total.
Angiodynamic Inc (ANGO) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 2/28/2025, it has been observed that the corporation posted 0.03 earnings per share (EPS) during the time that was better than consensus figure (set at -0.13) by 0.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -102.22% per share during the next fiscal year.
Angiodynamic Inc (NASDAQ: ANGO) Trading Performance Indicators
You can see what Angiodynamic Inc (ANGO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.33. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.67, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.14 in one year’s time.
Technical Analysis of Angiodynamic Inc (ANGO)
Angiodynamic Inc (NASDAQ: ANGO) saw its 5-day average volume 1.02 million, a negative change from its year-to-date volume of 1.53 million. As of the previous 9 days, the stock’s Stochastic %D was 30.07%.
During the past 100 days, Angiodynamic Inc’s (ANGO) raw stochastic average was set at 52.25%, which indicates a significant increase from 18.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.55 in the past 14 days, which was higher than the 0.43 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.64, while its 200-day Moving Average is $10.60. Nevertheless, the first resistance level for the watch stands at $12.82 in the near term. At $14.19, the stock is likely to face the second major resistance level. The third major resistance level sits at $15.16. If the price goes on to break the first support level at $10.48, it is likely to go to the next support level at $9.52. The third support level lies at $8.14 if the price breaches the second support level.
Angiodynamic Inc (NASDAQ: ANGO) Key Stats
There are 41,200K outstanding shares of the company, which has a market capitalization of 471.32 million. As of now, sales total 292,500 K while income totals -33,990 K. Its latest quarter income was 75,710 K while its last quarter net income were -10,900 K.
